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Abstract: Recently, growing interest has been devoted to the investigation of 
compounds with antimicrobial activity due to rising cases of resistance of mic-
robes to known therapies. A reliable and versatile source of novel drug disco-
very was recently found among endophytic fungi. Hitherto, the research usu-
ally enclosed the in vitro evaluation of antimicrobial activity and chemical 
structure elucidation of biomolecules extracted from fungal material. There-
fore, this research was designed as an extension to previous investigations of 
endophytic fungi growing on conifer needles by means of conducting a mole-
cular docking study. The in silico methods were used with the main goal to 
make a contribution to the understanding of the mechanisms underlying the 
interaction of biomolecules isolated from fungus Phomopsis species and eight 
different types of receptors that belong to usually multidrug resistant bacterial 
pathogens. The results revealed valuable interactions with receptors 3G7B 
(Staphylococcus aureus’s gyrase B), 1F0K (1.9 Å structure of Escherichia 
coli’s transferase) and 1SHV (Klebsiella pneumoniae’s SHV-1 β-lactamase) 
thus pointing out the receptors that trigger antibiotic response upon activation 
by the most potent compounds 325-3, 325-5, phomoenamide and phomol. 
These findings also recommended further discovery of novel potent and broad-
spectrum antibiotics based on the structure of selected molecules. 
Keywords: endophytes; antibacterial activity; in silico drug discovery. 
INTRODUCTION 
Antimicrobial drug resistance represents a global health problem. In order to 
effectively undertake the challenge of antimicrobial resistance, indispensable and 
sustainable use of antibiotics is necessary in order to control the disease, but also 
fostering innovation and development of new molecules with antibiotic potential. 
Development of novel antimicrobial therapies is necessary in order to enable 
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substitution for the declining effectiveness of already existing antibiotics.1 Endo-
phytic fungi were recently recognised as a naturally occurring repository of pot-
ent compounds for novel drug discovery regarding the fact that they represent 
microorganisms that usually inhabit medicinally potent plants and thus may inhe-
rit their medicinal abilities.2–5 Endophytic fungi are defined as non-pathogenic 
microorganisms (bacteria or fungi) that are present in the inner tissues of plants 
and have a symbiotic relationship with their plant host by helping the host plant 
to overcome the invasion of pathogenic microorganisms by producing secondary 
metabolites.6–11 A literature survey revealed that for these molecules, a variety of 
pharmacological activities, such as antifungal, antibacterial, antiviral, cytotoxic, 
anti-oxidant, etc. have already been reported.12 In this regard, the authors have 
reported significant antibacterial activity coming from secondary metabolites of 
endophytic fungus Phomopsis species growing in Slovenian conifer forests.13 
It is common knowledge that many antimicrobials express their effect 
through specific interaction with receptor targets that are present in mic-
robes.14,15 Nowadays, in line with experimental in vitro testing of the activity 
and interactions between potential ligands and receptors, achievements in the 
field of computer science allow a unique opportunity for computer aided drug 
design and simulation.16–18 In silico methods enable high throughput screening 
for potential drug candidates and introduce scientifically more informative and 
rationalized pharmaceutical research. Bearing this in mind, as well as the already 
proven activity of biomolecules isolated from endophytic fungus Phomopsis 
species growing on conifer needles against Staphylococcus aureus and Esche-
richia coli,13 the present study undertook consideration of common target recep-
tors of known antibiotics related to these pathogens. It was decided that the anti-
microbial activity against G+ bacteria S. aureus should be investigated using rec-
eptors 3VSL (penicillin-binding protein 3 from methicilin-resistant S. aureus),19 
3G7B (S. aureus gyrase B)20 and 1JIJ (tyrosyl-tRNA synthetase of S. aureus).20 
In addition, receptor 3K3P from Streptococcus mutans (apo-form of D-alanine: 
D-alanine ligase),21 was included as a valuable clue in further understanding of 
the resistance of G+ type bacteria to known drugs. On the other hand, widely 
tested receptor targets for evaluation of antimicrobial activity on E. coli, as the 
most common representative of G– bacteria, were 1F0K (1.9 Å structure of E. 
coli’s transferase),22 1KZN (24 kDa domain of E. coli’s isomerase)21 and 4EMV 
(structure of E. coli’s topoisomerase ATP inhibitor).22 Furthermore, the authors 
emphasized the importance of 1SHV receptor from Klebsiella pneumoniae 
(SHV-1 β-lactamase)22 as an additional target for inhibition of G– type bacteria. 
Bioactive compounds labelled as 325-3 and 325-5, isolated from endophytic 
fungus Phomopsis species growing on conifer needles,13 were used as a refer-
ence for a thorough literature search for secondary metabolites from other Pho-
mopsis species strains, as well as structurally similar bioactive compounds.23–32 
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A set of molecules was selected that comprised phomoenamide and phomonitro-
ester, secondary metabolites from endophyte Phomopsis species strain PSU-D15 
with records on moderate in vitro antibacterial activity against Mycobacterium 
tuberculosis.23,24 Five structurally similar compounds, hybrid peptide–polyket-
ides named as curvularides A–E, obtained from the endophytic fungus Curvu-
laria geniculate and isolated from the limbs of Catunaregam tomentosa were 
further selected because of their demonstrated antifungal activity against Can-
dida albicans.25 The set was complemented with compounds 6 and 7 isolated 
from endophytic fungus Phomopsis species from Notobasis syriaca, which also 
showed considerate antibacterial, anti-algal and antifungal activity.26 Finally, 
phomol was recently promoted as a novel antibiotic isolated from Phomopsis 
species from the medicinal plant Erythrina crista-galli.27 
EXPERIMENTAL 
Molecular docking 
Molecular docking is a practical in silico method employed in order to predict the ori-
entation of a ligand in a receptor binding pocket.33,34 Freely available software Autodock v4.2 
(The Scripps Research Institute, La Jolla, CA, USA) was used to perform the docking studies, 
while analyses of the docking simulation was performed in AutoDockTools 1.5.6 (The 
Scripps Research Institute, La Jolla, CA, USA). Prior to docking simulation, the ligands and 
receptors were adequately prepared. The structures of the ligands were optimized to achieve 
the conformations with the minimum energy, while structures of the receptor were retrieved 
from Brookhaven protein data bank. Pre-calculation of a 3D grid of interaction energies was 
performed by AutoGrid based on a macromolecular target. Within this procedure, a cubic grid 
box and grid maps were created in order to represent the active region in which the native 
molecular structure is embedded.35 A grid of 40 points in x-, y- and z-direction with grid 
spacing of 0.375 Å was built centred on a ligand. The maximum number of energy evalu-
ations was 2.500.000. The Lamarckian genetic algorithm was used to identify the best con-
formers.36,37 A maximum of 100 independent conformers for each compound were considered 
during the simulation. The docking exercise was executed between flexible ligands (tested 
molecular structures) and rigid protein receptors, allowing an evaluation of the free binding 
energy of the ligand and the macromolecule. Docked conformations with best RMSD (root 
mean square deviation) scoring function of all docked conformation were evaluated together 
with established key interactions.38,39 
Preparation of receptors and ligand molecules 
Crystal structures of G+ and G- bacterial type receptors were obtained from the Protein 
Data Bank (https://www.rcsb.org/).20-22 A set of ligand molecules included compounds 325-3 
and 325-5, curvularides A–E, compounds 6 and 7, phomol, phomoenamide and phomonitro-
ester (Fig. 1).23-27 The antibiotic ampicillin served as the control ligand. All ligand molecules 
were set in their minimum energy conformations obtained by the MOPAC/AM1 method (job 
type: minimising the RMS gradient to 0.100; display: each iteration; AM1 theory; wave func-
tion: closed shell) in Chem 3D Ultra 7.0.0 (Surrey, UK). 
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Fig. 1. Chemical structure of compound 325-3 (A), 325-5 (B), curvularide A (C), curvularide 
B (D), curvularide C (E), curvularide D (F), curvularide E (G), compound 6 (H), compound 7 
(I), phomol (J), phomoenamide (K) and phomonitroester (L). 
RESULTS AND DISCUSSION 
As a result of the authors' previous research attempts, compounds 325-3 and 
325-5 were isolated from endophytic fungus Phomopsis sp. and their activity 
against Escherichia coli and Staphylococcus aureus strains was experimentally 
evaluated. To understand the mechanism underlying the interaction between 325-3 
or 325-5 and different type of receptors and to identify the receptor that triggers 
antibiotic response upon activation, a molecular docking study was further per-
formed. Additionally, the pool of ligands was enriched with ten more endophytic 
biomolecules found through a literature surveillance. The most stable conform-
ations proposed by docking study were selected based on the minimum binding 
energy contributing to more thermodynamically favoured pathway of the format-
ion of the docked structure. 
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Each interaction was evaluated through certain parameters, i.e., inhibition 
constant (Ki), RMSD value, free binding energy and potential presence of hydro-
gen bonds between the tested ligand and the receptor. In general, lower values of 
final and binding energies, lower values of inhibition constant, root mean square 
deviation (RMSD) with a threshold value of 2 Å and, in case of close interaction 
of the ligand and receptor, the potential for the formation of hydrogen bonds 
between them, may be considered as reliable indicators of potential binding of 
the tested ligand to a receptor.40 The coordinates of the central grid point of the 
maps for all the tested ligands are provided in Table S-I of the Supplementary 
material to this paper. 
The outcomes of the docking simulation for the 1F0K receptor with ligands 
(Table I and Table S-II of the Supplementary material) demonstrated that of the 
tested ligands, ampicillin exhibited the highest bonding potential by establishing 
2 hydrogen bonds (Fig. 2), and having the lowest free binding energy of –6.47 
kcal* mol–1, an inhibition constant (Ki) of 18.08 µM and an RMSD value of 5.08. 
When comparing the affinity of the other ligands to ampicillin, 325-3, 325-5, 
phomoenamide and phomol stood out. Of the afore-mentioned compounds, low-
est free binding energies were observed for compound 325-3 (–5.14 kcal mol–1), 
phomoenamide (–4.97 kcal mol–1) and 325-5 (–4.78 kcal mol–1). Interestingly, 
the lowest Ki value, which implies high binding potential for the 1F0K receptor, 
was noted for phomol (Ki = 60.52 µM), followed by compounds 325-3 (Ki = 
= 172.04 µM) and phomoenamide (Ki = 227.74 µM). The lowest RMSD value 
was observed in case of phomol (RMSD = 3.26), followed compounds 325-3 and 
325-5, which had the same RMSD value of 3.72 and phomoenamide with RMSD 
value of 4.46. Four hydrogen bonds were observed in case of compound 325-5 
and curvularide A, though both compounds bind only to the GLN289 amino acid 
on the receptor, while additional hydrogen bonds were established with the other 
amino acids LEU265, SER192 and GLN193. This may imply that the 2 binding 
pockets of receptor 1F0K were in close vicinity. Compound 325-3, phomol and 
phomoenamide established 3 hydrogen bonds with the receptor. Since 325-5 and 
phomoenamide formed hydrogen bonds through THR266 amino acid and both 
compound 325-3 and 325-5 formed hydrogen bonds with amino acid GLN289 on 
the 1F0K receptor, it is suspected that compounds 325-3, 325-5 and phomo-
enamide bind to the same receptor pocket. On the other hand, phomol formed 
hydrogen bonds with amino acids GLY190 and GLN193, implying that it did not 
bond to the same place as the other compounds. 
The analysis of docking results of ligands to 3G7B receptor showed, as 
expected, that among the investigated ligands, the lowest binding energy of –6.10 
kcal mol–1 was observed for the ampicillin control (Table II and Table S-III of 
the Supplementary material). Of all tested ligands, compound 325-3 had the low- 
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TABLE I. Extracted crystal and experimental data for the molecular complexes with the 1F0K 
receptor 
Tested ligand Free binding energy, kcal mol-1
Inhibition 
constant, µM RMSD 
Hydrogen bonds with receptor 
amino acids 
Ampicillin –6.47 18.08 5.08 THR266 
325-3 –5.14 172.04 3.72 GLN289 
325-5 –4.78 313.49 3.72 THR266 GLN289 
Curvularide A –4.76 324.52 6.17 LEU265, SER192, GLN193, 
GLN289 
Curvularide B –4.10 994.76 6.79 GLN289 
Curvularide C –4.70 361.64 4.74 VAL189 
Curvularide D –4.74 334.92 6.42 LEU265 
Curvularide E –4.73 343.80 4.90 GLU269 
Phomoenamide –4.97 227.74 4.46 THR266 
Compound 6 –3.88 1430 7.35 LEU265, THR266 
Compound 7 –4.56 454.39 5.83 ARG164, THR266 
Phomol –5.75 60.52 3.26 GLY190, GLN193 
Phomonitroester –4.81 296.63 5.89 GLU269, GLN289 
 
Fig. 2. Docking pose of ligands 325-3 (A), 325-5 (B), phomoenamide (C) and ampicillin (D) 
with binding pocket of 1F0K receptor. Only the portion of the receptor with interacting amino 
acid residues is displayed. Main hydrogenic bonds between ligand amino acid residues in 
receptor pocket are emphasized in green. 
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est binding energy of –5.27 kcal mol–1. Moreover, a low binding energy with the 
3G7B receptor was also observed for phomoenamide and the 325-5 ligand. 
In addition, docking simulation revealed the establishment of 4 hydrogen 
bonds between the receptor 3G7B and both the ligand 325-3 and phomoenamide. 
Furthermore, 3 hydrogen bonds were observed between compound 325-3 and the 
3G7B receptor. Similar binding spots on the 3G7B receptor (amino acids on 
positions ASP57, ASN54 and VAL131 of 3G7B receptor, Table S-III) were obs-
erved for both compounds 325-3 and 325-5 (Fig. 3), which may explain the anti-
microbial activity against S. aureus experimentally observed in previous res-
earch. This also implied that compounds 325-3 and 325-5 interact with the same 
binding spot on the receptor, while phomoenamide or ampicillin bind to the other 
pockets of the 3G7B receptor. The lowest RMSD values were noted for phomo-
enamide (RMSD 3.27) and compound 325-5 (RMSD 3.92). Moreover, other 
tested ligands showed potential for interaction and binding with the 3G7B recep-
tor. However, according to the free binding energy, the constant of inhibition and 
the RMSD value, compounds 325-3 (Ki = 135.56 µM, RMSD 5.04), 325-5 
(Ki = 425.42 µM, RMSD 3.92) and phomoenamide (Ki = 397.98 µM, RMSD 
3.27) showed the greatest potential. 
TABLE II. Extracted crystal and experimental data for molecular complexes with the 3G7B 
receptor 
Tested ligand Free binding energy, kcal mol-1
Inhibition 
constant, µM RMSD 
Hydrogen bonds with receptor 
amino acids 
Ampicillin –6.10 33.93 5.77 ASP53, GLU50 
325-3 –5.27 135.56 5.04 ASP57, ASN54, VAL131 
325-5 –4.60 425.42 3.92 ASP57VAL131, ASN54 
CurvularideA –2.58 12930 4.21 ASP53, GLU50, ASN54 
CurvularideB –4.36 632.03 3.98 GLU50, HIS46 
CurvularideC –3.21 4440 4.50 ASP57 
CurvularideD –4.51 495.24 4.19 ASP53, ASN54, VAL131 
CurvularideE –4.47 532.45 4.15 ASP52, ASN54 
Phomoenamide –4.64 397.98 3.27 ASN54, GLU50 
Compound 6 –3.75 1790 6.72 VAL131, ASN54, GLU50 
Compound 7 –4.20 838.08 4.80 ASN54, VAL131 
Phomol –3.74 1800 4.89 ASP53, ASN206 
Phomonitroester –3.88 1440 6.80 VAL130, GLU50, HIS46, 
VAL131 
These results suggest that the highest affinity for the receptor 3G7B was 
observed for the ampicillin antibiotic control. Of the tested ligands, slightly lower 
affinity was noted for ligands 325-3, 325-5 and phomoenamide. Interestingly, 
binding places for ampicillin and phomoenamide included interactions in the 
receptor pocket in the vicinity of amino acid GLU50, while both compounds 
325-3 and 325-5 included interactions with amino acids ASP57, ASP54 and 
________________________________________________________________________________________________________________________
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VAL131 on different receptor spot (Fig. 3). There was a difference in binding 
locations of the aforementioned compounds, which implied potential differences 
in mechanism of action of ampicillin and phomoenamide in comparison to 325-3 
and 325-3. 
 
Fig. 3. Docking pose of ligands 325-3 (A), 325-5 (B), phomoenamide (C) and ampicillin (D) 
with 3G7B receptor binding pocket. Only the portion of the receptor with interacting amino 
acid residues is displayed. The main hydrogenic bonds between ligand amino acid residues in 
the receptor pocket are emphasized in green. 
It is known that antibiotics can exhibit their effect through inhibition of 
β-lactamase. Therefore, docking simulations between SHV-1 β-lactamase as rec-
eptor and all the investigated ligands were performed and evaluated (Tables III 
and S-IV (Supplementary material)). Ampicillin exhibited the lowest free binding 
energy of –1.90 kcal mol–1 and an RMSD of 5.08. However, compounds 6 and 
phomonitroester had the lowest free binding energy (–2.85 and –2.67 kcal mol–1, 
respectively), followed by compound 6 (–2.48 kcal mol–1) and compound 325-5 
(–1.79 kcal mol–1). This might imply that they potentially have greater affinity 
for the receptor in comparison to the ampicillin control. For all compounds, 
higher values for the inhibition constants were observed, with the lowest value of 
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8.10 mM for compound 7. Moreover, 4 hydrogen bonds were obtained in the 
case of compound 7 and phomonitroester, while 3 potential hydrogen bonds were 
formed between compound 325-5 and amino acids ARG202 and ARG205 on the 
1SHV receptor. 
TABLE III. Crystal and experimental data for molecular complexes with the 1SHV receptor 
Tested ligand Free binding energy, kcal mol-1
Inhibition 
constant, µM RMSD 
Hydrogen bonds with 
receptor amino acids 
Ampicillin –1.90 40320 5.08 ARG205 
325-3 0.33 N.A. 7.26 ARG205 
325-5 –1.79 48870 5.65 ARG202, ARG205 
CurvularideA –0.41 497240 5.07 ARG202 
CurvularideB –0.92 210410 7.41 ARG202ARG205 
CurvularideC 0.75 N.A. 4.74 None 
CurvularideD –1.57 70350 6.97 ARG202, ARG205 
CurvularideE –1.27 116590 5.05 ARG202, ARG205 
Phomoenamide –1.78 49500 6.51 GLU92 
Compound 6 –2.48 15230 7.48 ARG202, ARG205 
Compound 7 –2.85 8100 5.97 ARG202, ARG205 
Phomol –0.55 395820 5.28 ARG202, ARG205 
Phomonitroester –2.67 11060 7.46 ARG202, ARG205 
Overall, a lower binding potential was observed in case of docking of all the 
tested ligands with 1SHV receptor in comparison to both the 1F0K and 3G7B 
receptors. Moreover, the highest affinity for the 1SHV receptor was observed for 
compound 7 followed by phomonitroester, the ampicillin control and compound 
325-5. For all ligands, the binding pocket within the receptor seemed to be the 
same, since all hydrogen bonds were formed with amino acids on position 
ARG202 and ARG205 (Fig. 4). 
In docking simulations with receptor 3VSL, all compounds showed a weak 
potential for interaction (Table S-V). None of the compounds had the potential to 
form hydrogen bonds, also the values of the free binding energy were high, 
implying a weak potential for any interaction, and hence the inhibition constant 
could not be calculated. A similar lack of interaction potential for all tested 
compounds with 4EMV, 1JIJ, 1KZN and 3K3P receptor was also evident (Tables 
S-VI–IX of the supplementary material). According to the obtained data, it 
seemed that none of the investigated compounds interacted with these receptors. 
CONCLUSIONS 
As an extension of practical in vitro experiments for antimicrobial evalu-
ation, separation and characterization of the biomolecules of endophytic fungi, in 
silico molecular docking was proposed with the aim to introduce additional effort 
and to reliably recognize which active structures could serve as leading molecules 
for further in silico antibiotic drug discovery. Within this study, light was shed on  
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Fig. 4. Docking pose of ligands 325-5 (A), compound 7 (B), phomonitroester (C) and 
ampicillin (D) with the 1SHV receptor binding pocket. Only the portion of the receptor with 
interacting amino acid residues is displayed. The main hydrogenic bonds between the ligand 
amino acid residues in receptor pocket are emphasized in green. 
the interactions between a series of twelve compounds and their potential tar-
geted receptors. According to the overall criteria for docking evaluations, which 
included the value of the free binding energy, constant of inhibition, RMSD value 
and potential for establishment of hydrogen bonds with the receptor, it was 
concluded that the highest potential for docking interaction was observed in case 
of 3G7B, 1F0K and 1SHV receptors located in pathogens Staphylococcus aur-
eus, Escherichia Coli and Klebsiella pneumonia. The results from this docking 
study suggest that structural similarities as well as some specific properties of 
compounds 325-3, 325-5, phomoenamide and phomol may hopefully be used as 
directions for the further development of their derivatives as novel antibiotics 
with potent, broad-spectrum activity. In addition, these findings may also indi-
cate how to perform further optimization of biomolecule production by endo-
phytic fungi and/or more effective processing of gathered biomaterial. Moreover, 
the investigated compounds might also interact with other targets involving 
different mechanisms of action. 
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И З В О Д  
СТУДИЈА МОЛЕКУЛСКОГ ДОКИНГА СА БИОМОЛЕКУЛИМА ИЗОЛОВАНИМ ИЗ 
ЕНДОФИТНИХ ГЉИВА 
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1Катедра за аналитику лекова, Универзитет у Београду – Фармацеутски факултет, Војводе Степе 
450, 11221 Београд и 2Faculty of Pharmacy, University of Ljubljana, Aškerčeva cesta 7, 
1000 Ljubljana, Slovenia 
У последње време, као одговор на повећање резистенције микроорганизама на 
познату терапију, све већа пажња се поклања истраживању једињења са антимикробном 
активношћу. Ендофитне гљиве су недавно представљене као поуздан и богат извор за 
развој нових лекова. До сада, истраживања су се углавном ограничавала на in vitro про-
цену антимикробне активности и разоткривање хемијске структуре биомолекула изоло-
ваних из материјала гљива. Из тог разлога, ово истраживање је осмишљено као проши-
рење претходно спроведених испитивања ендофита које расту на иглицама четинара 
путем in silico студије молекулског докинга. Главни циљ употребе in silico метода је био 
да се направи прилог разумевању механизама који стоје иза интеракције биомолекула 
изолованих из гљиве Phomopsis species са осам различитих типова рецептора који при-
падају патогеним бактеријама уобичајено мултирезистентних на лекове. Резултати су 
указали на важне интеракције са рецепторима 3G7B (Staphylococcus aureus гираза Б), 
1F0K (структура Escherichia Coli трансферазе величине 1,9 Å) и 1SHV (SHV-1 β-лакта-
маза Klebsiella pneumoniae) указујући на тај начин на рецепторе путем којих се започиње 
антибиотски одговор након активације најпотентнијим једињењима, 325-3, 325-5, фомо-
енамидом и фомолом. Овим открићем се такође препоручује будући развој нових моћ-
них антибиотика са широким спектром деловања базиран на структури изабраних моле-
кула. 
(Примљено 15. августа 2020, ревидирано 10. јануара, прихваћено 23. јануара 2021) 
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